CorWave key facts
- Developer of innovative implanted cardiac support devices designed to help patients suffering from heart failure and offer them an active life.
- CorWave’s last known valuation is $108.7M.
- It has raised $102.8M; the latest was Later Stage VC ($33.9M) in May 2024.
- Notable investors include Bpifrance, MedTech Innovator, La French Tech, Agoranov, Novo Holdings — 19 tracked in total.
- Status: Privately Held (backing).
Who backs CorWave
19+Membership and data by Private Market View
- ·The complete investor list: 19 names
- ·Watch CorWave: the Monday email on marks, rounds and moves
CorWave funding rounds
No funding rounds for CorWave are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
CorWave valuation
CorWave's last known valuation is $109 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
CorWave investors
19 investors are on record for CorWave, including Bpifrance, MedTech Innovator, La French Tech and Agoranov.
About CorWave
Developer of innovative implanted cardiac support devices designed to help patients suffering from heart failure and offer them an active life. The company's devices consist of an implantable heart pump based on wave membrane pumping technology, enabling patients to lessen their suffering from complications and reduce the pain and burden from invasive surgery.
- Sector
- Healthcare
- HQ
- Clichy, France
- Founded
- 2011
- Employees
- 112
- Website
- corwave.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
CorWave’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.